DexCom, Inc. (DXCM) Q3 2016 Earnings Results

Dexcom Misses on EPS, Stock Down 0.41%

Dexcom's earnings report shows a significant miss on EPS, which may raise concerns among investors about the company's short-term profitability. The stock reacted by declining 0.41%, reflecting investor apprehension. Without specific revenue figures or guidance, uncertainty about future performance remains high.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.22	N/A	-58.27%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Defensive

Management expressed concerns about current performance but remains focused on long-term growth. They highlighted the importance of innovation in their strategy.

Management acknowledged challenges in achieving profitability this quarter.

They emphasized ongoing investments in product development and market expansion.

Dexcom Misses on EPS, Stock Down 0.41%

Key numbers

Management commentary

DexCom, Inc.

More earnings this week

Dexcom Misses on EPS, Stock Down 0.41%

Key numbers

Management commentary